Brand Names: Benicar, Benicar HCT, Azor, Tribenzor
Benicar is a blood pressure medication that may cause rare and serious gastrointestinal disease.
Blood pressure medications Benicar, Benicar HCT, Azor, and Tribenzor are under investigation for connection with sprue-like enteropathy, a potentially lethal disease which prevents the intestinal system from properly absorbing nutrients from food.
Often misdiagnosed as celiac disease, sprue-like enteropathy prevents the intestinal system from properly absorbing nutrients from food. Essentially, a patient who is not treated for this serious condition literally starves to death.
About the Benicar Litigation
Lenze Moss is currently investigating the use of the blood pressure medication Benicar (olmesartan medoxomil) and the development of a rare and serious gastrointestinal disease known as sprue-like enteropathy.
In 2013, the FDA recommended label change detailing the connection between Benicar and sprue-like enteropathy. For more information on this label change, see: http://www.fda.gov/Drugs/DrugSafety/ucm359477.htm
Benicar lawsuits are currently being filed in a multidistrict litigation (MDL) in the District of New Jersey. LM is actively pursuing the litigation in the discovery stage. If you or a loved one has been potentially injured by the use of Benicar, Benicar HCT, Azor, or Tribenzor, please contact us.